How tissue injury alarms the immune system and causes a systemic inflammatory response syndrome

Annals of Intensive Care

Volumn 2, Issue 1, 2012, Pages

  Pugin, Jérôme ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Alarmins; Danger signals; Inflammation; Mitochondria; Pro inflammatory cytokines; SIRS

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKINE; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; MITOCHONDRIAL PROTEIN; PROTEIN ANTIBODY; PROTEIN S 100; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; CYTOKINE RELEASE; DRUG EFFICACY; EXTRACELLULAR MATRIX; HUMAN; IMMUNOSTIMULATION; INJURY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THEORY; VACCINATION;

EID: 84866100477     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-2-27     Document Type: Article

References (43)

1. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992, 268:3452-3455.
2. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101:1481-1483.
3. Pittet D, Rangel-Frausto S, Li N, et al: Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995, 21:302-309.
4. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS) A prospective study. JAMA 1995, 273:117-123.
5. Dear VJL: SIRS I'm sorry to say that I don't like you. Crit Care Med 1997, 25:372-374.
6. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
7. Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI: Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med 2011, 39:322-327.
8. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993, 269:1829-1835.
9. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR: Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996, 153:1850-1856.
10. Dugernier TL, Laterre PF, Wittebole X, et al: Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003, 168:148-157.
11. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001, 163:316-321.
12. de Jong HK, van der Poll T, Wiersinga WJ: The systemic pro-inflammatory response in sepsis. J Innate Immun 2010, 2:422-430.
13. Pugin J: Dear SIRS, the concept of alarmins makes a lot of sense!. Intensive Care Med 2008, 34:218-221.
14. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
15. Matzinger P: An innate sense of danger. Ann N Y Acad Sci 2002, 961:341-342.
16. Matzinger P: The danger model: a renewed sense of self. Science 2002, 296:301-305.
17. Dreifus C: A Conversation With Polly Matzinger; Blazing an Unconventional Trail to a New Theory of Immunity: The New York Times; 1998.
18. Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.
19. Adib-Conquy M, Cavaillon JM: Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett 2007, 581:3723-3733.
20. Oppenheim JJ, Tewary P, de la Rosa G, Yang D: Alarmins initiate host defense. Adv Exp Med Biol 2007, 601:185-194.
21. Iyer SS, Pulskens WP, Sadler JJ, et al: Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 2009, 106:20388-20393.
22. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
23. Yang R, Harada T, Mollen KP, et al: Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 2006, 12:105-114.
24. Levy RM, Mollen KP, Prince JM, et al: Systemic Inflammation and Remote Organ Injury Following Trauma Require HMGB1. Am J Physiol Regul Integr Comp Physiol 2007, 293(4):R1538-44.
25. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, et al: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005, 33:564-573.
26. Kokkola R, Andersson A, Mullins G, et al: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005, 61:1-9.
27. Yu M, Wang H, Ding A, et al: HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006, 26:174-179.
28. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H: Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 2007, 81:49-58.
29. Tsan MF: Heat shock proteins and high mobility group box 1 protein lack cytokine function. J Leukoc Biol 2011, 89:847-853.
30. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P: HMGB1: guiding immunity from within. Trends Immunol 2005, 26:381-387.
31. Harris HE, Raucci A: Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 2006, 7:774-778.
32. Raucci A, Palumbo R, Bianchi ME: HMGB1: a signal of necrosis. Autoimmunity 2007, 40:285-289.
33. Calderwood SK, Mambula SS, Gray PJ Jr: Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 2007, 1113:28-39.
34. Foell D, Wittkowski H, Roth J: Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nature clinical practice 2007, 3:382-390.
35. Foell D, Wittkowski H, Vogl T, Roth J: S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007, 81:28-37.
36. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
37. Bonilla WV, Frohlich A, Senn K, et al: The alarmin interleukin-33 drives protective antiviral CD8 T cell responses. Science 2012, 335:984-989.
38. Dyall SD, Brown MT, Johnson PJ: Ancient invasions: from endosymbionts to organelles. Science 2004, 304:253-257.
39. Krysko DV, Agostinis P, Krysko O, et al: Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011, 32:157-164.
40. Zhang Q, Raoof M, Chen Y, et al: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
41. Jaecklin T, Otulakowski G, Kavanagh BP: Do soluble mediators cause ventilatorinduced lung injury and multi-organ failure? Intensive Care Med 2010, 36:750-757.
42. Mariathasan S, Weiss DS, Newton K, et al: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
43. McDonald B, Pittman K, Menezes GB, et al: Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.